SCHEMBL2936063

SCHEMBL2936063

O=C(O)C(=O)/C=C\c1ccccc1O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 2/20 0.71
CA1 P00915 1/20 0.71
CA2 P00918 1/20 0.71
CA4 P22748 1/20 0.71
JUN P05412 1/20 0.68
NFE2L2 Q16236 1/20 0.68
MAPT P10636 3/20 0.63
LMNA P02545 1/20 0.63
BCHE P06276 1/20 0.59
GUSB P08236 1/20 0.59
CHRNA7 P36544 3/20 0.54
TRPA1 O75762 1/20 0.53
MAPK1 P28482 2/20 0.53
CDK4 P11802 1/20 0.52
CCND1 P24385 1/20 0.52
ALPL P05186 1/20 0.51
ALPI P09923 1/20 0.51
ALPG P10696 1/20 0.51
KDM4E B2RXH2 1/20 0.51
NPC1 O15118 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2936064 1.00 NFKB1 (0.71) NFKB1CA1CA2CA4JUN
SCHEMBL2936065 1.00 NFKB1 (0.71) NFKB1CA1CA2CA4JUN
SCHEMBL27781270 0.86 NFKB1 (0.70) NFKB1CA1CA2CA4JUN
SCHEMBL12189733 0.85 IAPP (0.66) NFKB1CA1CA2CA4JUN
SCHEMBL7591687 0.84 NFKB1 (0.61) NFKB1CA1CA2CA4JUN
O-Coumaric Acid SCHEMBL29353381 0.83 NFKB1 (1.00) NFKB1CA1CA2CA4JUN
O-Coumaric Acid SCHEMBL64886 0.83 NFKB1 (1.00) NFKB1CA1CA2CA4JUN
O-Coumaric Acid SCHEMBL29367602 0.83 NFKB1 (1.00) NFKB1CA1CA2CA4JUN
O-Coumaric Acid SCHEMBL64885 0.83 NFKB1 (1.00) NFKB1CA1CA2CA4JUN
O-Coumaric Acid SCHEMBL892006 0.83 NFKB1 (1.00) NFKB1CA1CA2CA4JUN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260009056-A1 PRODUCTION OF CHEMICALS FROM RENEWABLE SOURCES ZYMOCHEM INC (US) 2026-01-08 US disclosed
US-12258610-B2 Production of chemicals from renewable sources ZYMOCHEM, INC. (US) 2025-03-25 US disclosed
US-11692208-B2 Production of chemicals from renewable sources ZYMOCHEM, INC. (US) 2023-07-04 US disclosed
US-20230109883-A1 PRODUCTION OF CHEMICALS FROM RENEWABLE SOURCES ZYMOCHEM, INC. 2023-04-13 US disclosed
US-20220372528-A1 PRODUCTION OF CHEMICALS FROM RENEWABLE SOURCES ZYMOCHEM, INC. 2022-11-24 US disclosed
EP-3959328-A1 PRODUCTION OF CHEMICALS FROM RENEWABLE SOURCES Zymochem, Inc. (US) 2022-03-02 EP disclosed
CN-114026246-A Production of chemicals from renewable sources 兹莫克姆有限公司 2022-02-08 CN disclosed
WO-2020220001-A1 PRODUCTION OF CHEMICALS FROM RENEWABLE SOURCES ZYMOCHEM, INC. (US) 2020-10-29 WO disclosed
US-8313936-B2 Nucleic acids and polypeptides involved in the production of cryptophycin REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2012-11-20 US disclosed
US-20120220008-A1 NUCLEIC ACIDS AND POLYPEPTIDES INVOLVED IN THE PRODUCTION OF CRYPTOPHYCIN REGENTS OF THE UNIVERSITY OF MICHIGAN 2012-08-30 US disclosed
US-20080090277-A1 NUCLEIC ACIDS AND POLYPEPTIDES INVOLVED IN THE PRODUCTION OF CRYPTOPHYCIN NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-04-17 US disclosed
EP-1751279-A4 NUCLEIC ACIDS AND POLYPEPTIDES INVOLVED IN THE PRODUCTION OF CRYPTOPHYCIN UNIV MINNESOTA (US) 2008-03-19 EP disclosed
US-20080050796-A1 Nucleic Acids and Polypeptides Involved in the Production of Cryptophycin REGENTS OF THE UNIVERSITY OF MINNESOTA, A MINNESOTA CORPORATION 2008-02-28 US disclosed
US-7229814-B2 Nucleic acids and polypeptides involved in the production of cryptophycin REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2007-06-12 US disclosed
EP-1751279-A2 NUCLEIC ACIDS AND POLYPEPTIDES INVOLVED IN THE PRODUCTION OF CRYPTOPHYCIN REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2007-02-14 EP disclosed
US-20060095982-A1 Phytoremediation of contaminant compounds via chloroplast genetic engineering UNIVERSITY OF CENTRAL FLORIDA (US) 2006-05-04 US disclosed
US-20060057698-A1 Nucleic acids and polypeptides involved in the production of cryptophycin NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2006-03-16 US disclosed
WO-2005116200-A2 NUCLEIC ACIDS AND POLYPEPTIDES INVOLVED IN THE PRODUCTION OF CRYPTOPHYCIN REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2005-12-08 WO disclosed
US-20030215859-A1 DNA shuffling of monooxygenase genes for production of industrial chemicals MAXYGEN, INC. 2003-11-20 US disclosed
US-6605430-B1 Genetic engineering to produce library of polynucleotides encoding polypeptides; screening, recovering MAXYGEN, INC. 2003-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260009056-A1 PRODUCTION OF CHEMICALS FROM RENEWABLE SOURCES HPD, PGD, ADSL NFKB1 3307/4885CA1 4418/4885CA2 3901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.